dipyridamole has been researched along with Dysgeusia in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.
Excerpt | Relevance | Reference |
---|---|---|
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported." | 5.27 | Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985) |
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported." | 1.27 | Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goy, JJ | 1 |
Finci, L | 1 |
Sigwart, U | 1 |
1 other study available for dipyridamole and Dysgeusia
Article | Year |
---|---|
Dysgeusia after high dose dipyridamole treatment (short communication).
Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Dysgeusia; Humans; Male; Taste Disorders | 1985 |